TMC Life Sciences Bhd
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; propert… Read more
TMC Life Sciences Bhd (0101) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of November 2025: 0.020x
Based on the latest financial reports, TMC Life Sciences Bhd (0101) has a cash flow conversion efficiency ratio of 0.020x as of November 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM16.96 Million) by net assets (RM860.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
TMC Life Sciences Bhd - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how TMC Life Sciences Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
TMC Life Sciences Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TMC Life Sciences Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Doral Group Renewable Energy Resources Ltd
TA:DORL
|
0.011x |
|
Lan Fa Textile Co Ltd
TW:1459
|
0.027x |
|
Hyweb Technology Co Ltd
TWO:5212
|
0.089x |
|
Verde Agritech PLC
TO:NPK
|
0.062x |
|
Sunjin Beauty Science Co. Ltd.
KQ:086710
|
0.054x |
|
Allied Digital Services Limited
NSE:ADSL
|
-0.049x |
|
Ottawa Savings Bancorp Inc
OTCQX:OTTW
|
-0.024x |
|
REC Silicon ASA
PINK:RNWEF
|
0.044x |
Annual Cash Flow Conversion Efficiency for TMC Life Sciences Bhd (2006–2025)
The table below shows the annual cash flow conversion efficiency of TMC Life Sciences Bhd from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-08-31 | RM853.04 Million | RM22.51 Million | 0.026x | -70.80% |
| 2024-08-31 | RM888.03 Million | RM80.23 Million | 0.090x | +42.70% |
| 2023-08-31 | RM861.96 Million | RM54.57 Million | 0.063x | +46.01% |
| 2022-08-31 | RM827.39 Million | RM35.88 Million | 0.043x | +52.51% |
| 2021-08-31 | RM789.62 Million | RM22.45 Million | 0.028x | +21.41% |
| 2020-08-31 | RM772.12 Million | RM18.08 Million | 0.023x | -40.88% |
| 2019-08-31 | RM762.24 Million | RM30.19 Million | 0.040x | +13.48% |
| 2018-08-31 | RM740.24 Million | RM25.84 Million | 0.035x | +151.91% |
| 2017-08-31 | RM714.42 Million | RM9.90 Million | 0.014x | -75.44% |
| 2016-08-31 | RM634.26 Million | RM35.79 Million | 0.056x | +58.75% |
| 2015-08-31 | RM301.71 Million | RM10.72 Million | 0.036x | -58.89% |
| 2014-08-31 | RM135.39 Million | RM11.71 Million | 0.086x | +40.65% |
| 2013-08-31 | RM131.31 Million | RM8.07 Million | 0.061x | +297.50% |
| 2012-08-31 | RM120.19 Million | RM-3.74 Million | -0.031x | -134.12% |
| 2011-08-31 | RM66.04 Million | RM6.02 Million | 0.091x | -25.70% |
| 2009-08-31 | RM103.54 Million | RM12.71 Million | 0.123x | +178.84% |
| 2008-08-31 | RM114.02 Million | RM-17.75 Million | -0.156x | -213.70% |
| 2007-08-31 | RM75.33 Million | RM10.32 Million | 0.137x | -47.73% |
| 2006-08-31 | RM48.97 Million | RM12.83 Million | 0.262x | -- |